Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene

详细信息    查看全文

• 作者：Haiqing Ma (1)
  Desheng Weng (1)
  Yibing Chen (1)
  Wei Huang (1)
  Ke Pan (1)
  Hui Wang (1)
  Jiancong Sun (1)
  Qijing Wang (1)
  Zhiwei Zhou (2)
  Huiyun Wang (1)
  Jianchuan Xia (1)
  
• 刊名：Molecular Cancer
• 出版年：2010
• 出版时间：December 2010
• 年：2010
• 卷：9
• 期：1
• 全文大小：1982KB
• 参考文献：1. Phan AT, Ajani JA: Gastric carcinoma. / Curr Oncol Rep 2004,6(3):192鈥?98. CrossRef
  2. Nishizuka S, Tamura G, Terashima M, Satodate R: Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach. / Br J Cancer 1997,76(12):1567鈥?571. CrossRef
  3. Xia JC, Weng DS, Li JT, Qin HD, Mai SJ, Feng BJ, Fan Q, Feng QS, Huang LX, Yu XJ, Pan ZZ, Li YQ, Wang QJ, Zhan YQ, Chen SP, He J, Huang WL, Wu PH, Zeng YX: Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31. / Cancer Genet Cytogenet 2006,166(2):166鈥?72. CrossRef
  4. Wang HY, Luo M, Tereshchenko IV, Frikker DM, Cui X, Li JY, Hu G, Chu Y, Azaro MA, Lin Y, Shen L, Yang Q, Kambouris ME, Gao R, Shih W, Li H: A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome. / Genome Res 2005,15(2):276鈥?83. CrossRef
  5. Zenklusen JC, Conti CJ, Green ED: Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. / Nat Genet 2001,27(4):392鈥?98. CrossRef
  6. Engelman JA, Zhang XL, Galbiati F, Lisanti MP: Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). / FEBS Lett 1998,429(3):330鈥?36. CrossRef
  7. Drusco A, Zanesi N, Roldo C, Trapasso F, Farber JL, Fong LY, Croce CM: Knockout mice reveal a tumor suppressor function for Testin. / Proc Natl Acad Sci USA 2005,102(31):10947鈥?0951. CrossRef
  8. Gunduz E, Gunduz M, Beder L, Nagatsuka H, Fukushima K, Sutcu R, Delibas N, Yamanaka N, Shimizu K, Nagai N: Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma. / Arch Otolaryngol Head Neck Surg 2009,135(3):254鈥?60. CrossRef
  9. Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CM: Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. / Clin Cancer Res 2005,11(2 Pt 1):806鈥?13.
  10. Tatarelli C, Linnenbach A, Mimori K, Croce CM: Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. / Genomics 2000,68(1):1鈥?2. CrossRef
  11. Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM: The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. / Oncogene 2001,20(22):2844鈥?853. CrossRef
  12. Jones PA, Taylor SM: Cellular differentiation, cytidine analogs and DNA methylation. / Cell 1980,20(1):85鈥?3. CrossRef
  13. Li JT, Fu L, Xia JC, Feng BJ, Mai SJ, Yu XJ, Huang LX, Feng QS, Pan ZZ, Zhan YQ: Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance. / Ai Zheng 2005,24(11):1306鈥?311.
  14. Weng DS, Li JT, Mai SJ, Pan ZZ, Feng BJ, Feng QS, Huang LX, Wang QJ, Li YQ, Yu XJ, Chen SP, He J, Xia JC: Identification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity. / World J Gastroenterol 2006,12(15):2437鈥?440.
  15. Barresi V, Giuffre G, Vitarelli E, Todaro P, Tuccari G: Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. / Virchows Arch 2008,453(6):571鈥?78. CrossRef
  16. Zhang HK, Pan K, Wang H, Weng DS, Song HF, Zhou J, Huang W, Li JJ, Chen MS, Xia JC: Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. / Cancer Lett 2008,261(2):183鈥?92. CrossRef
  17. Chene L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P, Latil A: Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. / Int J Cancer 2004,111(5):798鈥?04. CrossRef
  18. Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. / Trends Genet 2000,16(4):168鈥?74. CrossRef
  19. Singal R, Ginder GD: DNA methylation. / Blood 1999,93(12):4059鈥?070.
  20. Huang Q, Sacks PG, Mo J, McCormick SA, Iacob CE, Guo L, Schaefer S, Schantz SP: A simple method for fixation and microdissection of frozen fresh tissue sections for molecular cytogenetic analysis of cancers. / Biotech Histochem 2005,80(3鈥?):147鈥?56. CrossRef
  21. Zhang HK, Ma HQ, Wang QJ, Chen MS, Weng DS, Wang H, Zhou J, Li YQ, Sun JC, Chen YB, Liang XT, Zhao JJ, Pan K, Wang H, Xia JC: Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. / Oncol Rep 2010,23(2):445鈥?5.
  22. Pastinen T, Kurg A, Metspalu A, Peltonen L, Syvanen AC: Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. / Genome Res 1997,7(6):606鈥?14.
  23. Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen AC: A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. / Genome Res 2000,10(7):1031鈥?042. CrossRef
  24. Shumaker JM, Metspalu A, Caskey CT: Mutation detection by solid phase primer extension. / Hum Mutat 1996,7(4):346鈥?54. CrossRef
  25. Hu G, Wang HY, Greenawalt DM, Azaro MA, Luo M, Tereshchenko IV, Cui X, Yang Q, Gao R, Shen L, Li H: AccuTyping: new algorithms for automated analysis of data from high-throughput genotyping with oligonucleotide microarrays. / Nucleic Acids Res 2006,34(17):e116. CrossRef
  
• 作者单位：Haiqing Ma (1)
  Desheng Weng (1)
  Yibing Chen (1)
  Wei Huang (1)
  Ke Pan (1)
  Hui Wang (1)
  Jiancong Sun (1)
  Qijing Wang (1)
  Zhiwei Zhou (2)
  Huiyun Wang (1)
  Jianchuan Xia (1)
  
  1. State Key Laboratory of Oncology in Southern China and Department of Experimental Research, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China
  2. Department of Gastric Pancreatic Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China
  
• ISSN：1476-4598

文摘

Background High frequency of loss of heterozygosity (LOH) was found at D7S486 in primary gastric cancer (GC). And we found a high frequency of LOH region on 7q31 in primary GC from China, and identified D7S486 to be the most frequent LOH locus. This study was aimed to determine what genes were affected by the LOH and served as tumor suppressor genes (TSGs) in this region. Here, a high-throughput single nucleotide polymorphisms (SNPs) microarray fabricated in-house was used to analyze the LOH status around D7S486 on 7q31 in 75 patients with primary GC. Western blot, immunohistochemistry, and RT-PCR were used to assess the protein and mRNA expression of TESTIN (TES) in 50 and 140 primary GC samples, respectively. MTS assay was used to investigate the effect of TES overexpression on the proliferation of GC cell lines. Mutation and methylation analysis were performed to explore possible mechanisms of TES inactivation in GC. Results LOH analysis discovered five candidate genes (ST7, FOXP2, MDFIC, TES and CAV1) whose frequencies of LOH were higher than 30%. However, only TES showed the potential to be a TSG associated with GC. Among 140 pairs of GC samples, decreased TES mRNA level was found in 96 (68.6%) tumor tissues when compared with matched non-tumor tissues (p < 0.001). Also, reduced TES protein level was detected in 36 (72.0%) of all 50 tumor tissues by Western blot (p = 0.001). In addition, immunohistochemical staining result was in agreement with that of RT-PCR and Western blot. Down regulation of TES was shown to be correlated with tumor differentiation (p = 0.035) and prognosis (p = 0.035, log-rank test). Its overexpression inhibited the growth of three GC cell lines. Hypermethylation of TES promoter was a frequent event in primary GC and GC cell lines. However, no specific gene mutation was observed in the coding region of the TES gene. Conclusions Collectively, all results support the role of TES as a TSG in gastric carcinogenesis and that TES is inactivated primarily by LOH and CpG island methylation.